These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


119 related items for PubMed ID: 17435838

  • 41. Anti-cyclic citrullinated peptide (CCP) antibodies in patients with long-standing rheumatoid arthritis and their relationship with extra-articular manifestations.
    Korkmaz C, Us T, Kaşifoğlu T, Akgün Y.
    Clin Biochem; 2006 Oct; 39(10):961-5. PubMed ID: 16979149
    [Abstract] [Full Text] [Related]

  • 42. [Predictive values of anti-cyclic citrullinated peptide antibody, antikeratin antibody and rheumatoid factor in diagnosing articular erosions in patients with rheumatoid arthritis].
    Xie QB, Yin G.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 May; 40(3):508-12. PubMed ID: 19627016
    [Abstract] [Full Text] [Related]

  • 43. Prevalence and predictive value of anti-cyclic citrullinated protein antibodies for future development of rheumatoid arthritis in early undifferentiated arthritis.
    Emad Y, Shehata M, Ragab Y, Saad A, Hamza H, Abou-Zeid A.
    Mod Rheumatol; 2010 Aug; 20(4):358-65. PubMed ID: 20364358
    [Abstract] [Full Text] [Related]

  • 44. Antibodies to Cyclic Citrullinated Peptides in Patients With Juvenile Idiopathic Arthritis and Patients With Rheumatoid Arthritis: Shared Expression of the Inherently Autoreactive 9G4 Idiotype.
    Peckham H, Cambridge G, Bourke L, Sen D, Radziszewska A, Leandro M, Ioannou Y.
    Arthritis Rheumatol; 2017 Jul; 69(7):1387-1395. PubMed ID: 28380667
    [Abstract] [Full Text] [Related]

  • 45. Selected cyclic citrullinated peptides derived from the sequence of mutated and citrullinated vimentin (MCV) are targeted by different antibodies subclasses in patients with rheumatoid arthritis in Russian patients.
    Derganova O, Martinez-Gamboa L, Egerer K, Bang H, Fredenhagen G, Roggenbuck D, Esaulenko I, Burmester GR, Chernykh T, Feist E.
    Clin Exp Rheumatol; 2014 Jul; 32(5):622-9. PubMed ID: 25189876
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Antibodies to citrullinated peptides are not associated with the rate of joint destruction in patients with a well-established diagnosis of rheumatoid arthritis.
    Nieto-Colonia AM, Santos WS, Keusseyan SP, Caldana W, Fernandes AR, Andrade LE.
    Braz J Med Biol Res; 2008 Mar; 41(3):188-92. PubMed ID: 18235966
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Clinical utility of the anti-CCP assay in patients with rheumatic diseases.
    Lee DM, Schur PH.
    Ann Rheum Dis; 2003 Sep; 62(9):870-4. PubMed ID: 12922961
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. [New biomarkers for rheumatoid arthritis].
    Hayashi N, Nishimura K, Kumagai S.
    Rinsho Byori; 2008 Apr; 56(4):297-308. PubMed ID: 18516964
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis.
    Rantapää-Dahlqvist S, de Jong BA, Berglin E, Hallmans G, Wadell G, Stenlund H, Sundin U, van Venrooij WJ.
    Arthritis Rheum; 2003 Oct; 48(10):2741-9. PubMed ID: 14558078
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 6.